27569088|t|Prevalence of HPV genotypes in cervical adenocarcinoma: a study in Greek women
27569088|a|To study the prevalence of human papillomavirus (HPV) genotypes among cervical adenocarcinomas in Greek women. The study group comprised 78 adenocarcinoma cases (20 in situ and 58 invasive). HPV DNA was amplified using polymerase chain reaction (PCR) and HPV genotypes were identified by reverse hybridization. There was a high prevalence of HPV infection both for in situ (95%) or invasive (94.83%) adenocarcinomas, comprising also cancers of unusual morphology. HPV 16 was the commonest strain (N=57, 73.08%) followed by HPV 18 (N=28, 35.90%). Interestingly, 13 cases (16.67%) were also HPV 52 positive (as co-infection with HPV 16 or 18). All other strains with the exception of HPV 66 were found only as co-infections. No significant age difference was noted in terms of any HPV strain positivity. HPV DNA was found in the large majority of cervical adenocarcinomas. As opposed to other studies, HPV 52 was the third most commonly encountered strain after HPV 16 and HPV 18. The above findings would probably be of help in decision making concerning vaccination policy for the prevention of HPV infection in Greece.
27569088	0	10	Prevalence	T081	C0033105
27569088	14	17	HPV	T005	C0021344
27569088	18	27	genotypes	T032	C0017431
27569088	31	54	cervical adenocarcinoma	T191	C0279672
27569088	58	63	study	T062	C2603343
27569088	67	72	Greek	T098	C0337806
27569088	73	78	women	T098	C0043210
27569088	82	87	study	T062	C2603343
27569088	92	102	prevalence	T081	C0033105
27569088	106	126	human papillomavirus	T005	C0021344
27569088	128	131	HPV	T005	C0021344
27569088	133	142	genotypes	T032	C0017431
27569088	149	173	cervical adenocarcinomas	T191	C0279672
27569088	177	182	Greek	T098	C0337806
27569088	183	188	women	T098	C0043210
27569088	194	205	study group	UnknownType	C0681860
27569088	219	233	adenocarcinoma	T191	C0001418
27569088	234	239	cases	T077	C1706256
27569088	244	251	in situ	T191	C0007099
27569088	259	267	invasive	T191	C1334274
27569088	270	277	HPV DNA	T114,T123	C3872595
27569088	282	291	amplified	T045	C0683230
27569088	298	323	polymerase chain reaction	T063	C0032520
27569088	325	328	PCR	T063	C0032520
27569088	334	337	HPV	T005	C0021344
27569088	338	347	genotypes	T032	C0017431
27569088	353	363	identified	T080	C0205396
27569088	367	388	reverse hybridization	T063	C0221902
27569088	402	417	high prevalence	T081	C0033105
27569088	421	434	HPV infection	T047	C0343641
27569088	444	451	in situ	T191	C0007099
27569088	461	494	invasive (94.83%) adenocarcinomas	T191	C1334274
27569088	512	519	cancers	T191	C0006826
27569088	523	541	unusual morphology	T080	C0332437
27569088	543	549	HPV 16	T005	C0999806
27569088	558	567	commonest	T081	C0205214
27569088	568	574	strain	T001	C1518614
27569088	602	608	HPV 18	T005	C0999807
27569088	643	648	cases	T077	C1706256
27569088	668	683	HPV 52 positive	T005	C3641016
27569088	688	700	co-infection	T047	C0275524
27569088	706	712	HPV 16	T005	C0999806
27569088	716	718	18	T005	C0999807
27569088	731	738	strains	T001	C1518614
27569088	748	757	exception	T077	C1705847
27569088	761	767	HPV 66	T005	C3641020
27569088	787	800	co-infections	T047	C0275524
27569088	817	831	age difference	T100	C0699810
27569088	858	861	HPV	T005	C0021344
27569088	862	868	strain	T001	C1518614
27569088	869	879	positivity	T033	C1446409
27569088	881	888	HPV DNA	T114,T123	C3872595
27569088	906	920	large majority	T054	C0680220
27569088	924	948	cervical adenocarcinomas	T191	C0279672
27569088	970	977	studies	T062	C0008972
27569088	979	985	HPV 52	T005	C3641016
27569088	1005	1013	commonly	T081	C0205214
27569088	1014	1025	encountered	T058	C0422301
27569088	1026	1032	strain	T001	C1518614
27569088	1039	1045	HPV 16	T005	C0999806
27569088	1050	1056	HPV 18	T005	C0999807
27569088	1098	1102	help	T080	C1269765
27569088	1106	1121	decision making	T041	C0011109
27569088	1133	1144	vaccination	T061	C0042196
27569088	1145	1151	policy	T170	C0242456
27569088	1160	1170	prevention	T080	C2700409
27569088	1174	1187	HPV infection	T047	C0343641
27569088	1191	1197	Greece	T083	C0018226